Literature DB >> 25854268

Vascular calcifications on hand radiographs in rheumatoid arthritis and associations with autoantibodies, cardiovascular risk factors and mortality.

E Blair Solow1, Fang Yu2, Geoffrey M Thiele3, Jeremy Sokolove4, William H Robinson4, Zachary M Pruhs3, Kaleb D Michaud5, Alan R Erickson3, Harlan Sayles3, Gail S Kerr6, Angelo L Gaffo7, Liron Caplan8, Lisa A Davis8, Grant W Cannon9, Andreas M Reimold10, Joshua Baker11, Pascale Schwab12, Daniel R Anderson13, Ted R Mikuls14.   

Abstract

OBJECTIVE: To examine whether vascular calcifications on hand films in RA might aid in determining mortality risk.
METHODS: Hand radiographs from 906 RA patients were scored as positive or negative for vascular calcifications. Patient characteristics associated with vascular calcifications were assessed using multivariable logistic regression, and associations with mortality were examined using Cox proportional hazards regression. Cytokines and multiplex ACPA were measured in both groups.
RESULTS: A total of 99 patients (11%) demonstrated radiographic vascular calcifications. Factors independently associated with vascular calcifications included diabetes [odds ratio (OR) 2.85; 95% CI 1.43, 5.66], cardiovascular disease at enrolment (OR 2.48; 95% CI 1.01, 6.09), prednisone use (OR 1.90; 95% CI 1.25, 2.91), current smoking (OR 0.06; 95% CI 0.01, 0.23) and former smoking (OR 0.36; 95% CI 0.27, 0.48) vs never smoking. In cytokine and ACPA subtype analysis, IL-4 and anti-citrullinated apolipoprotein E were significantly increased in patients with vascular calcifications in fully adjusted multivariable models. After multivariable adjustment, vascular calcifications were associated with an increase in all-cause mortality (hazard ratio 1.41; 95% CI 1.12, 1.78; P = 0.004).
CONCLUSION: Vascular calcifications on hand radiographs were independently associated with increased all-cause mortality in RA. Mechanisms underpinning the associations of IL-4 and select ACPA with vascular calcifications and their utility as biomarkers predictive of cardiovascular disease risk in RA merit further study. Published by Oxford University Press on behalf of the British Society for Rheumatology 2015. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  anti-citrullinated protein autoantibodies; hand radiographs; mortality; rheumatoid arthritis; vascular calcifications

Mesh:

Substances:

Year:  2015        PMID: 25854268      PMCID: PMC4536858          DOI: 10.1093/rheumatology/kev027

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  42 in total

1.  Tumor necrosis factor α inhibitor use and decreased risk for incident coronary events in rheumatoid arthritis.

Authors:  Androniki Bili; Xiaoqin Tang; Shruthi Pranesh; Rasa Bozaite; Stephanie J Morris; Jana L Antohe; H Lester Kirchner; Mary Chester M Wasko
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-03       Impact factor: 4.794

2.  Vertebral fracture assessment-detected abdominal aortic calcification and cardiovascular disease in rheumatoid arthritis.

Authors:  Ausaf Mohammad; Derek Lohan; Diane Bergin; Sarah Mooney; John Newell; Martin O' Donnell; Shreyasee Amin; Robert J Coughlan; John J Carey
Journal:  Semin Arthritis Rheum       Date:  2013-10-05       Impact factor: 5.532

3.  Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis.

Authors:  Jeremy Sokolove; Dannette S Johnson; Lauren J Lahey; Catriona A Wagner; Danye Cheng; Geoffrey M Thiele; Kaleb Michaud; Harlan Sayles; Andreas M Reimold; Liron Caplan; Grant W Cannon; Gail Kerr; Ted R Mikuls; William H Robinson
Journal:  Arthritis Rheumatol       Date:  2014-04       Impact factor: 10.995

4.  Mortality rates in smokers and nonsmokers in the presence or absence of coronary artery calcification.

Authors:  John W McEvoy; Michael J Blaha; Juan J Rivera; Matthew J Budoff; Atif N Khan; Leslee J Shaw; Daniel S Berman; Paolo Raggi; James K Min; John A Rumberger; Tracy Q Callister; Roger S Blumenthal; Khurram Nasir
Journal:  JACC Cardiovasc Imaging       Date:  2012-10

5.  Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.

Authors:  Ulrike Harre; Dan Georgess; Holger Bang; Aline Bozec; Roland Axmann; Elena Ossipova; Per-Johan Jakobsson; Wolfgang Baum; Falk Nimmerjahn; Eszter Szarka; Gabriella Sarmay; Grit Krumbholz; Elena Neumann; Rene Toes; Hans-Ulrich Scherer; Anca Irinel Catrina; Lars Klareskog; Pierre Jurdic; Georg Schett
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

6.  Effect of body mass index on mortality and clinical status in rheumatoid arthritis.

Authors:  Frederick Wolfe; Kaleb Michaud
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

7.  Brief report: citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis.

Authors:  Jeremy Sokolove; Matthew J Brennan; Orr Sharpe; Lauren J Lahey; Amy H Kao; Eswar Krishnan; Daniel Edmundowicz; Christin M Lepus; Mary Chester Wasko; William H Robinson
Journal:  Arthritis Rheum       Date:  2013-07

8.  T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke.

Authors:  Daniel Engelbertsen; Linda Andersson; Irena Ljungcrantz; Maria Wigren; Bo Hedblad; Jan Nilsson; Harry Björkbacka
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-10       Impact factor: 8.311

Review 9.  (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis.

Authors:  Debby den Uyl; Mike T Nurmohamed; Lilian Hd van Tuyl; Hennie G Raterman; Willem F Lems
Journal:  Arthritis Res Ther       Date:  2011-01-17       Impact factor: 5.156

10.  Genetic variants of ApoE and ApoER2 differentially modulate endothelial function.

Authors:  Victoria Ulrich; Eddy S Konaniah; Joachim Herz; Robert D Gerard; Eunjeong Jung; Ivan S Yuhanna; Mohamed Ahmed; David Y Hui; Chieko Mineo; Philip W Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-02       Impact factor: 11.205

View more
  4 in total

1.  Apolipoprotein E Triggers Complement Activation in Joint Synovial Fluid of Rheumatoid Arthritis Patients by Binding C1q.

Authors:  Leonie M Vogt; Ewa Kwasniewicz; Simone Talens; Carsten Scavenius; Ewa Bielecka; Kristina N Ekdahl; Jan J Enghild; Matthias Mörgelin; Tore Saxne; Jan Potempa; Anna M Blom
Journal:  J Immunol       Date:  2020-04-06       Impact factor: 5.422

2.  Association of anti-citrullinated protein or peptide antibodies with left ventricular structure and function in rheumatoid arthritis.

Authors:  Laura Geraldino-Pardilla; Cesare Russo; Jeremy Sokolove; William H Robinson; Afshin Zartoshti; Jenny Van Eyk; Justyna Fert-Bober; Joao Lima; Jon T Giles; Joan M Bathon
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

3.  Association of Anti-Citrullinated Peptide Antibodies With Coronary Artery Calcification in Rheumatoid Arthritis.

Authors:  Laura Geraldino-Pardilla; Jon T Giles; Jeremy Sokolove; Afshin Zartoshti; William H Robinson; Matthew Budoff; Robert Detrano; Sabahat Bokhari; Joan M Bathon
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-07-10       Impact factor: 4.794

4.  Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.

Authors:  Piero Ruscitti; Paola Cipriani; Vasiliki Liakouli; Daniela Iacono; Ilenia Pantano; Domenico Paolo Emanuele Margiotta; Luca Navarini; Giulia Maria Destro Castaniti; Nicola Maruotti; Gerardo Di Scala; Licia Picciariello; Francesco Caso; Sara Bongiovanni; Rosa Daniela Grembiale; Fabiola Atzeni; Raffaele Scarpa; Federico Perosa; Giacomo Emmi; Francesco Paolo Cantatore; Giuliana Guggino; Antonella Afeltra; Francesco Ciccia; Roberto Giacomelli
Journal:  Arthritis Res Ther       Date:  2019-09-03       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.